PRF Technologies (PRFX) Retained Earnings (2019 - 2025)
PRF Technologies (PRFX) recorded quarterly Retained Earnings of -$61.3 million in Q4 2025, down 4.29% on a QoQ basis from -$58.8 million in Q2 2025, and down 8.57% year-over-year from -$67.0 million in Q4 2024.
PRF Technologies (PRFX) Retained Earnings (2019 - 2025) Analysis & Trends
PRF Technologies has disclosed Retained Earnings across 7 years of filings, most recently posting -$61.3 million for Q4 2025.
- Quarterly Retained Earnings fell 8.57% year-over-year to -$61.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$61.3 million (down 8.57% YoY) and the FY2025 annual result came in at -$61.3 million, down 8.57% from the prior year.
- Retained Earnings slipped to -$61.3 million in Q4 2025, from -$58.8 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$1.4 million in Q4 2023 and troughed at -$61.3 million in Q4 2025.
- A 5-year average of -$34.6 million and a median of -$32.5 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2023 — Retained Earnings jumped 95.56% — and 2024, when it plunged 3809.35%.
- Tracing PRFX's Retained Earnings over 5 years: stood at -$23.7 million in 2021, then tumbled by 37.05% to -$32.5 million in 2022, then jumped by 95.56% to -$1.4 million in 2023, then tumbled by 3809.35% to -$56.5 million in 2024, then fell by 8.57% to -$61.3 million in 2025.
- Business Quant data shows PRFX's Retained Earnings at -$61.3 million in Q4 2025, -$58.8 million in Q2 2025, and -$56.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | PRF Technologies | 933,081.16 | -2.46 Mn | - | -61.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -61.29 Mn |
| Jun 30, 2025 | -58.77 Mn |
| Dec 31, 2024 | -56.45 Mn |
| Jun 30, 2024 | -54.68 Mn |
| Mar 31, 2024 | -47.37 Mn |
| Dec 31, 2023 | -1.44 Mn |
| Sep 30, 2023 | -36.97 Mn |
| Jun 30, 2023 | -37.01 Mn |
| Mar 31, 2023 | -34.83 Mn |
| Dec 31, 2022 | -32.52 Mn |
| Sep 30, 2022 | -29.35 Mn |
| Jun 30, 2022 | -27.24 Mn |
| Mar 31, 2022 | -25.42 Mn |
| Dec 31, 2021 | -23.73 Mn |
| Sep 30, 2021 | -21.99 Mn |
| Jun 30, 2021 | -20.22 Mn |
| Mar 31, 2021 | -18.52 Mn |
| Dec 31, 2020 | -16.48 Mn |
| Jun 30, 2020 | -14.39 Mn |
| Dec 31, 2019 | -12.43 Mn |